Investigation of exocrine pancreatic function by continuous infusion of caerulein and secretin in normal subjects and in chronic pancreatitis.
Exocrine pancreatic function has been evaluated in 24 controls and 29 patients with confirmed chronic pancreatitis by continuous infusion (90 min) of synthetic caerulein, 100 ng/kg/h, plus GIH secretin, 1 CU/kg/h. Mean secretory values of the controls were comparable to those obtained by others using maximal doses of secretin and CCK. Unlike the controls, patients suffering from chronic pancreatitis demonstrated a progressive reduction in secretion during infusion. Thus, the comparison of responses for the final 30-min period gave much clearer and more complete discrimination between normal and abnormal pancreatic function than the preceding 30-min period.
D000293:Adolescent; D000328:Adult; D001639:Bicarbonates / Q000378:metabolism; D002108:Ceruletide; D002908:Chronic Disease; D002918:Chymotrypsin / Q000378:metabolism; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008049:Lipase / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010179:Pancreas / Q000378:metabolism*; D010195:Pancreatitis / Q000503:physiopathology*; D012633:Secretin / Q000008:administration & dosage; D012636:Secretory Rate / Q000187:drug effects; D014357:Trypsin / Q000378:metabolism
D001639:Bicarbonates; D012633:Secretin; D002108:Ceruletide; D008049:Lipase; D002918:Chymotrypsin; D014357:Trypsin